{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:16:11Z","timestamp":1792872971605,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC3502900"],"award-info":[{"award-number":["2023YFC3502900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2308200"],"award-info":[{"award-number":["2023YFC2308200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82304830"],"award-info":[{"award-number":["82304830"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Non-clinical pharmacology of traditional Chinese medicine (TCM) formulae plays a crucial role in elucidating their therapeutic mechanisms. With the integration of cutting-edge disciplines such as systems biology, big data, and artificial intelligence, the research depth and breadth in this field continue to expand. However, technical standards for non-clinical pharmacology research on TCM formulae have not yet been established. To address this, technical guidelines for non-clinical pharmacology research of TCM formulae were formed, aiming to scientifically standardize research content, elevate research quality, and facilitate the mutual translation between clinical and basic research. Guided by integrative pharmacology of TCM and driven by clinical value, these guidelines employ multi-dimensional qualitative pharmacokinetics (PK) and pharmacodynamics (PD) studies alongside quantitative \"PK-PD\" studies of key components. This approach enables the transition from panoramic description to precise mechanistic research, establishing a complete evidence chain system for the effectiveness of TCM formulae and demonstrating their holistic action characteristics of \"multi-component, multi-pathway, multi-target\". Meanwhile, the guidelines emphasize that animal models for TCM research should ensure stability and reproducibility. Additionally, pharmacodynamic evaluation is characterized by its measurability and quantifiability. The mechanisms of action at the molecular level should be in-depth and interpretable. These aspects collectively provide guidance for basic non-clinical pharmacology research on TCM formulae and the development of new TCM drugs. The formulation of these guidelines leveraged the research strengths of the drafting units' teams, incorporated literature review findings, and achieved consensus through extensive discussions among multidisciplinary experts. Broad expert opinions from universities, research institutes, and enterprises engaged in new drug development were solicited, ensuring the guidelines' practicality, standardization, scientific rigor, and feasibility.<\/jats:p>","DOI":"10.1186\/s13020-025-01277-w","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T23:02:08Z","timestamp":1764716528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Technical guidelines for non-clinical pharmacological research of traditional Chinese medicine (TCM) formulae"],"prefix":"10.1186","volume":"20","author":[{"given":"Weijie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"2","key":"1277_CR1","first-page":"113","volume":"11","author":"A Kuang","year":"1963","unstructured":"Kuang A. Effects of yang-tonifying herbs on exhaustion phenomena induced by high-dose corticosteroids. Chin J Intern Med. 1963;11(2):113\u20136.","journal-title":"Chin J Intern Med"},{"key":"1277_CR2","unstructured":"Liu J. Clinical Simulation Approaches for Syndrome-Disease Integrated Animal Models in TCM Research. People's Medical Publishing House (Beijing), 2014. (In Chinese)."},{"key":"1277_CR3","first-page":"18","volume":"06","author":"J Tian","year":"2005","unstructured":"Tian J, Wang Y, Shi J, Zhu A, Huang Q. Research thinking on syndrome model defined by traditional Chinese medicine. J Beijing Univ Tradit Chin Med. 2005;06:18\u201321 (In Chinese).","journal-title":"J Beijing Univ Tradit Chin Med"},{"issue":"05","key":"1277_CR4","first-page":"642","volume":"37","author":"F Dong","year":"2021","unstructured":"Dong F, Liu J. From \u201cexperience\u201d to \u201cevidence\u201d: evidence-based medicine facilitates the inheritance and innovation of traditional Chinese medicine. J Nanjing Univ Tradit Chin Med. 2021;37(05):642\u20137 (In Chinese).","journal-title":"J Nanjing Univ Tradit Chin Med"},{"issue":"01","key":"1277_CR5","first-page":"54","volume":"28","author":"X Xiao","year":"2009","unstructured":"Xiao X, Liu C. Metabolomics-driven exploration of active constituents and mechanisms in lipid-lowering traditional Chinese medicine. J Tianjin Univ Tradit Chin Med. 2009;28(01):54\u20136 (In Chinese).","journal-title":"J Tianjin Univ Tradit Chin Med"},{"key":"1277_CR6","volume-title":"Research progress of chinmedomics (2021)","author":"X Wang","year":"2023","unstructured":"Wang X. Research progress of chinmedomics (2021). Beijing: Science Press; 2023. (In Chinese)."},{"issue":"03","key":"1277_CR7","first-page":"270","volume":"44","author":"H Hao","year":"2009","unstructured":"Hao H, Deng C, Wang G. Thoughts and experimental exploration on pharmacokinetic study of herbal medicines with multiple-components and targets. Acta Pharm Sin. 2009;44(03):270\u20135 (In Chinese).","journal-title":"Acta Pharm Sin"},{"key":"1277_CR8","first-page":"395","volume":"05","author":"C Liu","year":"2005","unstructured":"Liu C. Difficulty and hot-points on pharmacokinetics studies of traditional Chinese medicine. Acta Pharm Sin. 2005;05:395\u2013401 ((In Chinese)).","journal-title":"Acta Pharm Sin"},{"issue":"12","key":"1277_CR9","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.16438\/j.0513-4870.2010.12.010","volume":"45","author":"A Liu","year":"2010","unstructured":"Liu A, Du G. Network pharmacology: new guidelines for drug discovery. Acta Pharm Sin. 2010;45(12):1472\u20137. https:\/\/doi.org\/10.16438\/j.0513-4870.2010.12.010. (In Chinese).","journal-title":"Acta Pharm Sin"},{"issue":"14","key":"1277_CR10","first-page":"4119","volume":"52","author":"M Niu","year":"2021","unstructured":"Niu M, Zhang S, Zhang B, Li S. Interpretation of network pharmacology evaluation method guidance. Chin Tradit Herb Drugs. 2021;52(14):4119\u201329 (In Chinese).","journal-title":"Chin Tradit Herb Drugs"},{"issue":"18","key":"1277_CR11","first-page":"5055","volume":"49","author":"S Li","year":"2024","unstructured":"Li S, Xiao W. General expert consensus on application of network pharmacology in research and development of new traditional Chinese medicine drugs. China J Chin Mater Med. 2024;49(18):5055\u201368 (In Chinese).","journal-title":"China J Chin Mater Med"},{"issue":"10","key":"1277_CR12","first-page":"898","volume":"30","author":"C Song","year":"2021","unstructured":"Song C, Liu B, Xue F, Han L. Investigation and considerations about clinical position and effect evaluation system and criterion suited for traditional Chinese medicine. Chin J New Drugs. 2021;30(10):898\u2013901 (In Chinese).","journal-title":"Chin J New Drugs"},{"issue":"02","key":"1277_CR13","first-page":"626","volume":"39","author":"X Lei","year":"2024","unstructured":"Lei X, Shang H, Gao C, Cui T, Cheng J. Thinking of constructing the evaluation system of clinical efficacy of traditional Chinese medicine based on clinical orientation. China J Tradit Chin Med Pharm. 2024;39(02):626\u201330 (In Chinese).","journal-title":"China J Tradit Chin Med Pharm"},{"issue":"03","key":"1277_CR14","first-page":"383","volume":"38","author":"L Huang","year":"2024","unstructured":"Huang L. Consideration on the key directions for fundamental research in science and technology innovation of traditional Chinese medicine. Bull Natl Nat Sci Found China. 2024;38(03):383\u20136 (In Chinese).","journal-title":"Bull Natl Nat Sci Found China"},{"issue":"01","key":"1277_CR15","first-page":"7","volume":"17","author":"G Luo","year":"2015","unstructured":"Luo G, Xie Y, Liang Q, Fan X, Wang Y. Integrated medicine for traditional Chinese medicine: the third discussion on the proposal of holistic system medicine. Moderniz Tradit Chin Med Mater Med World Sci Technol. 2015;17(01):7\u201315 (In Chinese).","journal-title":"Moderniz Tradit Chin Med Mater Med World Sci Technol"},{"key":"1277_CR16","unstructured":"National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) Guideline for Pharmacodynamic Studies of Traditional Chinese Medicine (Draft for Comment)[EB\/OL]. (2024\u201307\u201317)[2024\u201309\u201326] (In Chinese)."},{"issue":"03","key":"1277_CR17","first-page":"357","volume":"39","author":"H Xu","year":"2014","unstructured":"Xu H, Yang H. Integrative pharmacology:new paradigm of modernization of Chinese medicine. China J Chin Mater Med. 2014;39(03):357\u201362 (In Chinese).","journal-title":"China J Chin Mater Med"},{"key":"1277_CR18","volume-title":"Integrative pharmacology","author":"H Xu","year":"2021","unstructured":"Xu H, Yang H. Integrative pharmacology. Beijing: Science Press; 2021. (In Chinese)."},{"issue":"6","key":"1277_CR19","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.apsb.2021.03.024","volume":"11","author":"H Xu","year":"2021","unstructured":"Xu H, Zhang Y, Wang P, Zhang J, Chen H, Zhang L, et al. A comprehensive review of integrative pharmacology-based investigation: a paradigm shift in traditional Chinese medicine. Acta Pharm Sin B. 2021;11(6):1379\u201399.","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"1277_CR20","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1016\/j.apsb.2023.03.012","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li X, Shi Y, Chen T, Xu Z, Wang P, et al. ETCM v2.0: an update with comprehensive resource and rich annotations for traditional Chinese medicine. Acta Pharm Sin B. 2023;13(6):2559\u201371.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"1277_CR21","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1002\/imt2.80","volume":"2","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xu J, Yu Z, Chen T, Wang N, Du X, et al. Ontology characterization, enrichment analysis, and similarity calculation-based evaluation of disease-syndrome-formula associations by applying SoFDA. Imeta. 2023;2(2):e80.","journal-title":"Imeta"},{"issue":"11","key":"1277_CR22","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.scib.2022.03.013","volume":"67","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang N, Du X, Chen T, Yu Z, Qin Y, et al. SoFDA: an integrated web platform from syndrome ontology to network-based evaluation of disease-syndrome-formula associations for precision medicine. Sci Bull. 2022;67(11):1097\u2013101.","journal-title":"Sci Bull"},{"issue":"21","key":"1277_CR23","first-page":"5443","volume":"46","author":"J Wang","year":"2021","unstructured":"Wang J, Xiao X. On indirect actions of Chinese medicines and innovation of indirect-acting Chinese medicines. China J Chin Mater Med. 2021;46(21):5443\u20139 (In Chinese).","journal-title":"China J Chin Mater Med"},{"issue":"06","key":"1277_CR24","first-page":"1","volume":"25","author":"H Xu","year":"2019","unstructured":"Xu H, Hou W, Li K, Shen Y, Tang S, Guo F, et al. Discovery and application of quality marker of traditional Chinese medicine based on integrative pharmacology. Chin J Exp Tradit Med Formulae. 2019;25(06):1\u20138 (In Chinese).","journal-title":"Chin J Exp Tradit Med Formulae"},{"issue":"18","key":"1277_CR25","doi-asserted-by":"publisher","first-page":"e2301775120","DOI":"10.1073\/pnas.2301775120","volume":"120","author":"H Xu","year":"2023","unstructured":"Xu H, Li S, Liu J, Cheng J, Kang L, Li W, et al. Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19. Proc Natl Acad Sci U S A. 2023;120(18):e2301775120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1277_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22111867","author":"G Kuang","year":"2017","unstructured":"Kuang G, Yi H, Zhu M, et al. Study of absorption characteristics of the total saponins from Radix Ilicis pubescentis in an in situ single-pass intestinal perfusion (SPIP) rat model by using ultra performance liquid chromatography (UPLC). Molecules. 2017. https:\/\/doi.org\/10.3390\/molecules22111867.","journal-title":"Molecules"},{"issue":"3","key":"1277_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejps.2011.04.011","volume":"43","author":"M Sun","year":"2011","unstructured":"Sun M, Zhai X, Xue K, et al. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats. Eur J Pharm Sci. 2011;43(3):132\u201340.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"1277_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1208\/s12249-021-01980-5","volume":"22","author":"KS Italiya","year":"2021","unstructured":"Italiya KS, Singh AK, Chitkara D, et al. Nanoparticulate tablet dosage form of lisofylline-linoleic acid conjugate for type 1 diabetes: in situ single-pass intestinal perfusion (SPIP) studies and pharmacokinetics in rat. AAPS PharmSciTech. 2021;22(3):114.","journal-title":"AAPS PharmSciTech"},{"issue":"1-2","key":"1277_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijpharm.2017.05.018","volume":"527","author":"I Lozoya-Agullo","year":"2017","unstructured":"Lozoya-Agullo I, Zur M, Fine-Shamir N, et al. Investigating drug absorption from the colon: single-pass vs. Doluisio approaches to in-situ rat large-intestinal perfusion. Int J Pharm. 2017;527(1\u20132):135\u201341.","journal-title":"Int J Pharm"},{"issue":"6","key":"1277_CR30","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1021\/acs.analchem.2c03767","volume":"95","author":"W Tang","year":"2023","unstructured":"Tang W, Zhang Y, Li P, et al. Evaluation of intestinal drug absorption and interaction using quadruple single-pass intestinal perfusion coupled with mass spectrometry imaging. Anal Chem. 2023;95(6):3218\u201327.","journal-title":"Anal Chem"},{"issue":"3","key":"1277_CR31","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.apsb.2016.09.005","volume":"7","author":"PB Shekhawat","year":"2017","unstructured":"Shekhawat PB, Pokharkar VB. Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles. Acta Pharm Sin B. 2017;7(3):260\u201380.","journal-title":"Acta Pharm Sin B"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01277-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01277-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01277-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T23:02:13Z","timestamp":1764716533000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-025-01277-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1277"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01277-w","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We declare that the Publisher has the Author\u2019s permission to publish the relevant Contribution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}